OncoImmune

OncoImmune

OncoImmune

OncoImmune is a clinical-stage company that engages in the discovery and development of biopharmaceuticals for the treatment of cancer.
Founded
2000
Raised
$56M
Follow us
Alexa global traffic share
Latest funding
Team Size
1–10
Employees
$56,000,000 Venture capital (Series B)
FinSMEs , DealStreetAsia

OncoImmune Raises $56M Series B Financing